Ignite Creation Date:
2025-12-24 @ 2:51 PM
Ignite Modification Date:
2026-01-29 @ 1:58 PM
Study NCT ID:
NCT00268359
Status:
COMPLETED
Last Update Posted:
2014-07-21
First Post:
2005-12-20
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bevacizumab and Irinotecan in Treating Patients With Recurrent or Refractory Gliomas
Sponsor:
Duke University
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Brain and Central Nervous System Tumors | View |